Deborah Rudin

11PUBLICATIONS
35CO-AUTHORS
Biologically active moleculesCharacterisation of biological macromoleculesMolecular medicineCellular nervous systemPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 05, 2026
5-HT2A receptor agonism by tert-leucinamide and valinamide synthetic cannabinoids: In vitro and in vivo evidence.

|Apr 28, 2026
Acute dose-dependent effects of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) compared with 3,4-methylenedioxymethamphetamine (MDMA) and psilocybin in a double-blind, placebo-controlled study in healthy participants.

|Nov 05, 2025
The 4-alkyl chain length of 2,5-dimethoxyamphetamines differentially affects in vitro serotonin receptor actions versus in vivo psychedelic-like effects.

Dino Luethi, Grant C Glatfelter, Eline Pottie

|Sep 25, 2025
Acute effects of MDMA, MDA, lysine-MDMA, and lysine-MDA in a randomized, double-blind, placebo-controlled, crossover trial in healthy participants.

Isabelle Straumann, Patrick Vizeli, Isidora Avedisian

|Sep 02, 2025
Cell membrane cholesterol affects serotonin transporter efflux due to altered transporter oligomerization.

Deborah Rudin, Dino Luethi, Marco Niello

|May 26, 2025
Absolute Oral Bioavailability and Bioequivalence of LSD Base and Tartrate in a Double-Blind, Placebo-Controlled, Crossover Study.

Denis Arikci, Friederike Holze, Lorenz Mueller

Pageof 2

Frequent Collaborators

9 joint publications

Dino Luethi

6 joint publications

Matthias E Liechti

3 joint publications

Patrick Vizeli

3 joint publications

Anne Eckert